No Data
No Data
13D Filings -- Barron's
Piper Sandler Maintains Soleno Therapeutics(SLNO.US) With Buy Rating, Maintains Target Price $93
Form 144 | Soleno Therapeutics(SLNO.US) Insider Proposes to Sell 51.42 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Oct 21, $Soleno Therapeutics(SLNO.US)$ Insider Abingworth Bioventures VII LP intends to sell 949.34K shares of its common stock on Oct 21, with a total market value of
Express News | Soleno Therapeutics Announces the Passing of Former Chairman Ernest Mario, Ph.d.
Press Release: Soleno Therapeutics Announces the Passing of Former Chairman Ernest Mario, Ph.D.
TriMas, Soleno Therapeutics, Ring Energy, and More Stocks See Action From Activist Investors -- Barrons.com